Sponsor Pipeline

Theriva Biologics SL Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-28 NCT07701486
A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients…		 Recruitment opened
2026-07-24 NCT07701486
A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients…		 Primary endpoint(s) modified
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07701486 A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients… Pancreas Cancer, Metastatic Recruiting
Get alerts when Theriva Biologics SL's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free